Palinta, Waning A.
HRN: 22-35-54 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2022
CEFUROXIME 1.5GM (VIAL)
12/25/2022
12/26/2022
IVT
1.5gms
Q8H
Increased WBC; UTI As LD
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes